A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer-Reference-Cited by-同舟云学术

A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer

Published:2019-06-08 Issue:5 Volume:31 Page:284-289
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Takahara Naminatsu¹,Isayama Hiroyuki¹²,Nakai Yousuke¹,Sasaki Takashi¹³,Saito Kei¹,Sato Tatsuya¹^ORCID,Hakuta Ryunosuke¹,Ishigaki Kazunaga¹,Saito Tomotaka¹,Hamada Tsuyoshi¹,Mizuno Suguru¹^ORCID,Kogure Hirofumi¹,Tada Minoru¹,Koike Kazuhiko¹

Affiliation:

1. Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;

2. Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan;

3. Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Funder

the Tokyo University Research Fund

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2019.1626088

Reference18 articles.

1. Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan

2. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

3. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

4. Phase II study of S-1 in patients with advanced biliary tract cancer

5. S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of cisplatin-induced apoptosis by saffron in human lung cancer cells;Journal of Trace Elements in Medicine and Biology;2023-09

2. Adjuvant Therapy in Gall Bladder Cancera;A Pictorial Treatise on Gall Bladder Cancer;2021

3. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy;Journal of Gastroenterology and Hepatology;2020-04-23